Agilent Technologies' stock is soaring 17.78% in intraday trading on Thursday, driven by the company's robust fiscal second-quarter financial performance and an upward revision to its full-year outlook.

The surge follows Agilent's report of better-than-expected Q2 results, with adjusted earnings per share of $1.49 surpassing analyst estimates of $1.41, and revenue of $1.835 billion exceeding expectations of $1.799 billion. Furthermore, the company raised its full-year 2026 adjusted profit forecast to a range of $6.00 to $6.10 per share, up from its prior guidance of $5.90 to $6.04, citing strong demand for its medical tools and laboratory equipment.

Positive analyst sentiment contributed to the momentum, with several brokerages including BofA Securities and Barclays upgrading their ratings on Agilent and raising their price targets following the solid quarterly beat and improved guidance.